Published in Nucleic Acids Res on July 10, 2015
Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers. Pharmaceuticals (Basel) (2016) 0.80
Opportunities in the design and application of RNA for gene expression control. Nucleic Acids Res (2016) 0.78
Screening and identification of DNA aptamers toward Schistosoma japonicum eggs via SELEX. Sci Rep (2016) 0.75
Prediction of aptamer-protein interacting pairs using an ensemble classifier in combination with various protein sequence attributes. BMC Bioinformatics (2016) 0.75
Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol (1994) 37.96
MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res (2009) 23.27
In vitro selection of functional nucleic acids. Annu Rev Biochem (1999) 6.55
Aptamers as therapeutics. Nat Rev Drug Discov (2010) 5.36
RNAshapes: an integrated RNA analysis package based on abstract shapes. Bioinformatics (2005) 3.20
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci U S A (2010) 2.01
Freiburg RNA Tools: a web server integrating INTARNA, EXPARNA and LOCARNA. Nucleic Acids Res (2010) 1.84
Phage display: concept, innovations, applications and future. Biotechnol Adv (2010) 1.77
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett (1986) 1.68
Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes. Nat Biotechnol (2014) 1.51
Probing the SELEX process with next-generation sequencing. PLoS One (2011) 1.34
Comprehensive analysis of RNA-protein interactions by high-throughput sequencing-RNA affinity profiling. Nat Methods (2014) 1.27
Exploring the sequence space of a DNA aptamer using microarrays. Nucleic Acids Res (2007) 1.25
Biochemical properties of plasminogen activator inhibitor-1. Front Biosci (Landmark Ed) (2009) 1.22
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization. Mol Ther Nucleic Acids (2014) 1.21
Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther (2012) 1.19
Aptamer selection by high-throughput sequencing and informatic analysis. Biotechniques (2011) 1.14
Quantitative selection and parallel characterization of aptamers. Proc Natl Acad Sci U S A (2013) 1.13
Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C. J Biol Chem (2006) 1.04
High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase. Nucleic Acids Res (2012) 1.02
Antimetastatic potential of PAI-1-specific RNA aptamers. Oligonucleotides (2009) 0.93
Massively parallel interrogation of aptamer sequence, structure and function. PLoS One (2008) 0.93
The RNA shapes studio. Bioinformatics (2014) 0.91
RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Biochemistry (2010) 0.90
Current progress of aptamer-based molecular imaging. J Nucl Med (2014) 0.88
Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry. ACS Chem Biol (2013) 0.86
Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding. RNA (2010) 0.85
Nucleic acid aptamers against proteases. Curr Med Chem (2011) 0.83
Mapping of the epitope of a monoclonal antibody protecting plasminogen activator inhibitor-1 against inactivating agents. Eur J Biochem (2003) 0.82